Serum Institute Of India
India  /  Published 29.06.21

Vaccine: EU travel a pain for Indians

Indian travellers who’ve had two shots of Covishield are out of luck if they want to travel to Europe under the European Union’s Digital Covid certificate. That’s despite the fact th...
By Paran Balakrishnan in New Delhi

India  /  Published 28.06.21

Covishield: SII prod to govt

Sources said referring to Poonawalla's letter, Director, Government and Regulatory Affairs at SII, Prakash Kumar Singh, has also sought Jaishankar's intervention at the highest level, saying, ...
By Our Bureau in Calcutta

India  /  Published 25.06.21

Poonawalla: Serum making 1st batch of Covovax

The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility, SII CEO Adar Poonawalla said on Friday. "Excit...
By Our Bureau, PTI in Pune

India  /  Published 15.06.21

Novovax: over 90% efficacy

By G.S. Mudur in New Delhi

Opinion  /  Published 07.06.21

The holes in the vaccine policy

The first phase of India’s Covid-19 mass vaccination programme was launched with healthcare professionals and other frontline workers on January 16, 2021. The second phase began on March 1; it w...
By Soumitra Ghosh


Business  /  Published 04.06.21

Serum Institute of India seeks indemnity

Serum Institute of India (SII) has sought indemnity protection against prosecution or lawsuits arising from any adverse effects for people taking its Covishield vaccine. Its demand comes at a time th...
By Our Bureau in Mumbai

India  /  Published 03.06.21

SII seeks nod to make Sputnik V in India

The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture Covid-19 vaccine Sputnik V in the country, sources said on Thursday. Th...
By Our Bureau, Agencies in Hyderabad

India  /  Published 23.05.21

SII: Do not agree with executive on jab shortage

The Serum Institute has disassociated itself from its executive director's statement that the government began the Covid-19 vaccination of multiple age groups without taking into consideration the...
By Our Bureau, Agencies in Pune

India  /  Published 22.05.21

Serum voice queries govt jab math

The executive director of the Pune-based Serum Institute of India (SII), which is producing the Covishield vaccine, on Friday alleged that the government began inoculating people from multiple age gro...
By PTI in New Delhi

West Bengal  /  Published 20.05.21

First jab within 45 days for priority groups

The Bengal government plans to administer at least one dose of Covid-19 vaccine to priority groups, who come in daily contact with many people, within the next 45 days as the state has started receivi...
By Our Special Correspondent in Calcutta


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.